Moreover; Fraga et al., (2008), documented that in hematological malignancies such as diffuse large B-cell lymphoma and AML, reintroduction of TLE1 into leukemia or lymphoma cells resulted in growth inhibition in vitro and in vivo. This evidence concerns the gene TLE1 and hematologic disorder.